Patent Assignment
Reel/Frame 045673/0079
Change of Name
Recorded: 2018-04-30
Pages: 3
Assignor
AVIRAGEN THERAPEUTICS, INC.
Executed: 2018-02-13
Assignee
VAXART, INC.
290 UTAH AVE, SUITE 200, SOUTH SAN FRANCISCO, CALIFORNIA, 94080
Covered Properties
(3)
Anhydrous Crystalline Free Base Form of 6-{2-[1-(6-Methyl-3-Pyridazinyl)-4-Piperidinyl]Ethoxy}-3-Ethoxy-1,2-Benzisoxazole
Anhydrous Crystalline Free Base Form of 6-{2-[1-(6-Methyl-3-Pyridazinyl)-4-Piperidinyl]Ethoxy}-3-Ethoxy-1,2-Benzisoxazole
Application:
15/713,289 →
Publication:
US 2018/0162849
Anhydrous Crystalline Free Base Form of 6-{2-[1-(6-Methyl-3-Pyridazinyl)-4-Piperidinyl]Ethoxy}-3-Ethoxy-1,2-Benzisoxazole
Application:
62/015,126 →
Related Assignments
(3)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Sep 16, 2014
From: MCALLISTER, DAVID; TRIGWELL, ANDREW
To: BIOTA SCIENTIFIC MANAGEMENT PTY LTD.
Reel/Frame 033750/0708 →
Assignment of Assignor's Interest
Aug 7, 2015
From: LEE, EDWARD; MCALLISTER, DAVID; TRIGWELL, ANDREW; TUOHY III, ROBERT VINCENT
To: BIOTA PHARMACEUTICALS, INC.
Reel/Frame 036275/0618 →
Assignment of Assignor's Interest
Jul 26, 2017
From: LEE, EDWARD; MCALLISTER, DAVID; TRIGWELL, ANDREW; TUOHY III, ROBERT VINCENT
To: AVIRAGEN THERAPEUTICS, INC.
Reel/Frame 043104/0803 →